{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:10:37Z","timestamp":1781719837064,"version":"3.54.5"},"reference-count":33,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-00947","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T22:07:44Z","timestamp":1493590064000},"page":"658-664","source":"Crossref","is-referenced-by-count":19,"title":["Caffeine Suppresses the Activation of Hepatic Stellate Cells cAMP-Independently by Antagonizing Adenosine Receptors"],"prefix":"10.1248","volume":"40","author":[{"given":"Momoka","family":"Yamaguchi","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ya","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misuzu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical and Bio-analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Todoroki","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical and Bio-analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Toyo\u2019oka","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical and Bio-analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev., 88, 125\u2013172 (2008).","DOI":"10.1152\/physrev.00013.2007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Atzori L, Poli G, Perra A. Hepatic stellate cell: a star cell in the liver. Int. J. Biochem. Cell Biol., 41, 1639\u20131642 (2009).","DOI":"10.1016\/j.biocel.2009.03.001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Senoo H. Structure and function of hepatic stellate cells. Med. Electron Microsc., 37, 3\u201315 (2004).","DOI":"10.1007\/s00795-003-0230-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Friedman SL. Cytokines and fibrogenesis. Semin. Liver Dis., 19, 129\u2013140 (1999).","DOI":"10.1055\/s-2007-1007105"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nwosu ZC, Alborzinia H, W\u00f6lfl S, Dooley S, Liu Y. Evolving insights on metabolism, autophagy, and epigenetics in liver myofibroblasts. Front. Physiol., 7, 191 (2016).","DOI":"10.3389\/fphys.2016.00191"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Li J-T, Liao Z-X, Ping J, Xu D, Wang H. Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J. Gastroenterol., 43, 419\u2013428 (2008).","DOI":"10.1007\/s00535-008-2180-y"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Jin X, Zheng R, Li Y. Green tea consumption and liver disease: a systematic review. Liver Int., 28, 990\u2013996 (2008).","DOI":"10.1111\/j.1478-3231.2008.01776.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, Hoofnagle JH. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology, 51, 201\u2013209 (2010).","DOI":"10.1002\/hep.23279"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kojima N, Hori M, Murata T, Morizane Y, Ozaki H. Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation. Br. J. Pharmacol., 151, 816\u2013827 (2007).","DOI":"10.1038\/sj.bjp.0707269"},{"key":"10","unstructured":"10) Abramoff MD, Magelh\u00e3es PJ, Ram SJ. Image processing with imageJ. ResearchGate, 11, 36\u201342 (2003)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Klinger M, Freissmuth M, Nanoff C. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell. Signal., 14, 99\u2013108 (2002).","DOI":"10.1016\/S0898-6568(01)00235-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Peng Z, Fernandez P, Wilder T, Yee H, Chiriboga L, Chan ESL, Cronstein BN. Ecto-5\u2032-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J., 22, 2263\u20132272 (2008).","DOI":"10.1096\/fj.07-100685"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Chan ESL, Montesinos MC, Fernandez P, Desai A, Delano DL, Yee H, Reiss AB, Pillinger MH, Chen J-F, Schwarzschild MA, Friedman SL, Cronstein BN. Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis. Br. J. Pharmacol., 148, 1144\u20131155 (2006).","DOI":"10.1038\/sj.bjp.0706812"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) New DC, Wu K, Kwok AWS, Wong YH. G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis. FEBS J., 274, 6025\u20136036 (2007).","DOI":"10.1111\/j.1742-4658.2007.06116.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Liu TZ, Wang X, Bai Y, Liao H, Qiu S, Yang Y, Yan X-H, Chen J, Guo H, Zhang S. The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor. Int. J. Biochem. Cell Biol., 49, 8\u201316 (2014).","DOI":"10.1016\/j.biocel.2014.01.007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Madi L, Rosenberg-Haggen B, Nyska A, Korenstein R. Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants. Exp. Dermatol., 22, 74\u201377 (2013).","DOI":"10.1111\/exd.12028"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Reif S, Lang A, Lindquist JN, Yata Y, Gabele E, Scanga A, Brenner DA, Rippe RA. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J. Biol. Chem., 278, 8083\u20138090 (2003).","DOI":"10.1074\/jbc.M212927200"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sun W-Y, Song Y, Hu S-S, Wang Q-T, Wu H-X, Chen J-Y, Wei W. Depletion of \u03b2-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway. J. Cell. Biochem., 114, 1153\u20131162 (2013).","DOI":"10.1002\/jcb.24458"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Rietz A, Volkov Y, Davies A, Hennessy M, Spiers JP. Okadaic acid induces matrix metalloproteinase-9 expression in fibroblasts: crosstalk between protein phosphatase inhibition and \u03b2-adrenoceptor signalling. Br. J. Pharmacol., 165, 274\u2013288 (2012).","DOI":"10.1111\/j.1476-5381.2011.01559.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, Oakley RH, Caron MG, Lefkowitz RJ, Luttrell LM. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J. Biol. Chem., 278, 6258\u20136267 (2003).","DOI":"10.1074\/jbc.M212231200"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Edling CE, Selvaggi F, Ghonaim R, Maffucci T, Falasca M. Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase\/Akt pathway. Cancer Biol. Ther., 15, 524\u2013532 (2014).","DOI":"10.4161\/cbt.28018"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Huang Y, Li X, Wang Y, Wang H, Huang C, Li J. Endoplasmic reticulum stress-induced hepatic stellate cell apoptosis through calcium-mediated JNK\/P38 MAPK and Calpain\/Caspase-12 pathways. Mol. Cell. Biochem., 394, 1\u201312 (2014).","DOI":"10.1007\/s11010-014-2073-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Ping A, Yihao T, Jingxing D, Minkai C, Hesheng L. Ca2+\/calmodulin-dependent protein kinase II mediates platelet-derived growth factor-induced human hepatic stellate cell proliferation. Dig. Dis. Sci., 57, 935\u2013942 (2012).","DOI":"10.1007\/s10620-011-2014-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kawada N, Kuroki T, Kobayashi K, Inoue M, Kaneda K. Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP. Dig. Dis. Sci., 41, 1022\u20131029 (1996).","DOI":"10.1007\/BF02091547"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ikeda N, Murata S, Maruyama T, Tamura T, Nozaki R, Kawasaki T, Fukunaga K, Oda T, Sasaki R, Homma M, Ohkohchi N. Platelet-derived adenosine 5\u2032-triphosphate suppresses activation of human hepatic stellate cell: in vitro study. Hepatol. Res., 42, 91\u2013102 (2012).","DOI":"10.1111\/j.1872-034X.2011.00893.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sohail MA, Hashmi AZ, Hakim W, Watanabe A, Zipprich A, Groszmann RJ, Dranoff JA, Torok NJ, Mehal WZ. Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology, 49, 185\u2013194 (2009).","DOI":"10.1002\/hep.22589"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Shim SG, Jun DW, Kim EK, Saeed WK, Lee KN, Lee HL, Lee OY, Choi HS, Yoon BC. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J. Gastroenterol. Hepatol., 28, 1877\u20131884 (2013).","DOI":"10.1111\/jgh.12317"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Wang H, Guan W, Yang W, Wang Q, Zhao H, Yang F, Lv X, Li J. Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP\/PKA\/SRC\/ERK1\/2\/P38 MAPK signal pathway. PLoS ONE, 9, e92482 (2014).","DOI":"10.1371\/journal.pone.0092482"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wang Q, Dai X, Yang W, Wang H, Zhao H, Yang F, Yang Y, Li J, Lv X. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP\/PKA\/CREB pathway in rat hepatic stellate cells. Int. Immunopharmacol., 25, 340\u2013352 (2015).","DOI":"10.1016\/j.intimp.2015.02.012"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Podzuweit T, Nennstiel P, M\u00fcller A. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine. Cell. Signal., 7, 733\u2013738 (1995).","DOI":"10.1016\/0898-6568(95)00042-N"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Reeves ML, Leigh BK, England PJ. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem. J., 241, 535\u2013541 (1987).","DOI":"10.1042\/bj2410535"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Tang KM, Jang EK, Haslam RJ. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors. Eur. J. Pharmacol., 268, 105\u2013114 (1994).","DOI":"10.1016\/0922-4106(94)90125-2"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hasegawa M, Yamada S, Hirayama C. Fasting plasma caffeine level in cirrhotic patients: relation to plasma levels of catecholamines and renin activity. Hepatology, 10, 973\u2013977 (1989).","DOI":"10.1002\/hep.1840100614"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/5\/40_b16-00947\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T15:44:50Z","timestamp":1498405490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/5\/40_b16-00947\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00947","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}